Literature DB >> 8047835

The binding of synovial tissue-derived human monoclonal immunoglobulin M rheumatoid factor to immunoglobulin G preparations of differing galactose content.

A J Soltys1, F C Hay, A Bond, J S Axford, M G Jones, I Randen, K M Thompson, J B Natvig.   

Abstract

There are several sites on IgG Fc that have been reported to be the epitopes for binding rheumatoid factors (RF). It is now established that there are alterations in the oligosaccharides on IgG from patients with rheumatoid arthritis and it has been suggested that these changes may enhance immune complex and cryoglobulin formation. We have used a series of IgG preparations differing in their content of oligosaccharide chains lacking galactose from 18 to 86% to determine whether changes in sugar content affect the binding of rheumatoid factor. Five of 16 monoclonal rheumatoid factors prepared from synovial tissue, from patients with juvenile or adult rheumatoid arthritis, bound better to IgG which was deficient in galactose. Six of the 16 rheumatoid factors from the same patients bound independently of the galactose content. Four of the 16 rheumatoid factors could not be absolutely grouped in this manner but seemed to demonstrate a preference for agalactosyl IgG. One rheumatoid factor bound better to fully galactosylated IgG. There was an association between enhanced binding to galactose-deficient IgG and monoreactivity and a very strong association between the functional affinity of the rheumatoid factors and the dependent binding.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8047835     DOI: 10.1111/j.1365-3083.1994.tb03442.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  15 in total

1.  Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis.

Authors:  Altan Ercan; Jing Cui; Dereck E W Chatterton; Kevin D Deane; Melissa M Hazen; William Brintnell; Colin I O'Donnell; Lezlie A Derber; Michael E Weinblatt; Nancy A Shadick; David A Bell; Ewa Cairns; Daniel H Solomon; V Michael Holers; Pauline M Rudd; David M Lee
Journal:  Arthritis Rheum       Date:  2010-08

Review 2.  The importance of oligosaccharides to rheumatic disease: a personal perspective.

Authors:  J S Axford
Journal:  Glycoconj J       Date:  1997-11       Impact factor: 2.916

Review 3.  Glycobiology and medicine: an introduction.

Authors:  J Axford
Journal:  J R Soc Med       Date:  1997-05       Impact factor: 5.344

4.  Rheumatoid factors: where are we now?

Authors:  A I Soltys; J S Axford; B J Sutton
Journal:  Ann Rheum Dis       Date:  1997-05       Impact factor: 19.103

5.  The changes in monosaccharide composition of immunoglobulin G in the course of rheumatoid arthritis.

Authors:  Ewa Gindzienska-Sieskiewicz; Piotr Adrian Klimiuk; Dariusz Gabriel Kisiel; Andrzej Gindzienski; Stanislaw Sierakowski
Journal:  Clin Rheumatol       Date:  2006-08-04       Impact factor: 2.980

6.  Screening neutral and acidic IgG N-glycans by high density electrophoresis.

Authors:  E R Frears; A H Merry; J S Axford
Journal:  Glycoconj J       Date:  1999-06       Impact factor: 2.916

7.  The glycosylation pattern of humanized IgGI antibody (D1.3) expressed in CHO cells.

Authors:  F H Routier; M J Davies; K Bergemann; E F Hounsell
Journal:  Glycoconj J       Date:  1997-02       Impact factor: 2.916

8.  The diagnostic utilities of anti-agalactosyl IgG antibodies, anti-cyclic citrullinated peptide antibodies, and rheumatoid factors in rheumatoid arthritis.

Authors:  Hee Jung Ryu; Fujio Takeuchi; Shoji Kuwata; Yoon Jun Kim; Eun Young Lee; Eun Bong Lee; Yeong Wook Song
Journal:  Rheumatol Int       Date:  2009-12-15       Impact factor: 2.631

9.  Label-free detection of immune complexes with myeloid cells.

Authors:  Z Szittner; A E H Bentlage; P Rovero; P Migliorini; V Lóránd; J Prechl; G Vidarsson
Journal:  Clin Exp Immunol       Date:  2016-05-12       Impact factor: 4.330

10.  Rheumatoid factor avidity in patients with rheumatoid arthritis: identification of pathogenic RFs which correlate with disease parameters and with the gal(0) glycoform of IgG.

Authors:  M M Newkirk; M J Fournier; J Shiroky
Journal:  J Clin Immunol       Date:  1995-09       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.